Vet Comp Orthop Traumatol 2018; 31(03): 218-221
DOI: 10.1055/s-0038-1632365
Brief Communication
Schattauer GmbH Stuttgart

Morbidity and Mortality Following Total Hip Replacement in Dogs

William D. Liska
1   Global Veterinary Specialists PLLC, Houston, Texas, United States
,
Sarah K. Israel
2   South Texas Veterinary Specialists - Bluepearl Stone Oak, San Antonio, Texas, United States
› Author Affiliations
Further Information

Publication History

19 June 2017

21 December 2017

Publication Date:
21 April 2018 (online)

Preview

Abstract

Objective The objective of this study was to determine morbidity and mortality rates in dogs that had undergone a total hip replacement surgery with implantation of either a cemented or a cementless prosthesis (BioMedtrix LLC, Whippany, NJ).

Methods The survival time after surgery, the date of death and the cause of death were collated from an ongoing registry maintained on consecutive total hip replacement procedures by a single surgeon.

Results A review of the 1,864 dogs entered in the total hip replacement registry revealed 642 in which the date of death and cause of death were known. The mean life span of the dogs in this study was 11.3 years, with the longest being 17.1 years. The mean survival after total hip replacement was 4.66 years, with the longest being 16.1 years. Multiorgan system failure was more common than any single organ system failure. The most common pathophysiological process leading to death was neoplasia.

Clinical Significance Morbidity and mortality rates are helpful for surgeons to compare outcomes and to inform animal owners about anaesthesia and procedural risks when contemplating this surgery. This information can be used for a better understanding of expectations for a dog's health after total hip replacement surgery.

Author contributions

W. Liska and S. Israel contributed to the conception of the study, study design, acquisition of data, and data analysis and interpretation. Both authors drafted and revised and approved the submitted manuscript.